期刊文献+
共找到119篇文章
< 1 2 6 >
每页显示 20 50 100
Thin-film hydration preparation method and stability test of DOX-loaded disulfide-linked polyethylene glycol 5000-lysine-di-tocopherol succinate nanomicelles 被引量:1
1
作者 Xiaoyu Ai Lu Zhong +1 位作者 Handong Niu Zhonggui He 《Asian Journal of Pharmaceutical Sciences》 SCIE CAS 2014年第5期244-250,共7页
A novel redox-responsive PEG-sheddable copolymer of disulfide-linked polyethylene glycol 5000-lysine-di-tocopherol succinate(P_(5k)SSLV)was designed and synthesized.Thin-film hydration method was used to prepare DOX-l... A novel redox-responsive PEG-sheddable copolymer of disulfide-linked polyethylene glycol 5000-lysine-di-tocopherol succinate(P_(5k)SSLV)was designed and synthesized.Thin-film hydration method was used to prepare DOX-loaded P_(5k)SSLV nanomicelle.To optimize the preparation technology,we investigate the effects of dosage,type of organic solvent,hydration temperature and time,and cryoprotectant on drug-loading content,encapsulation efficiency,particle size,and zeta potential.The mean particle size and zeta potential were determined by Zetasizer.The morphology of the P_(5k)SSLV-DOX nanomicelles was visualized by transmission electron microscopy.The drug-loading content and encapsulation efficiency of P_(5k)SSLV-DOX nanomicelle were investigated by UV.The drug-loading content,encapsulation efficiency,particle size,and zeta potential of the final optimized nanomicelles were 4.58%,97.20%,30.21 nm and -0.84 mV,respectively.In addition,the stability of nanomicelles was investigated,which included dilution stability and storage stability.The results showed that P_(5k)SSLV-DOX nanomicelle had good dilution stability and storage stability at 4℃.The preparation method of P_(5k)SSLV-DOX nanomicelle with thinfilm hydration method was practical and simple,which was valuable to be further studied. 展开更多
关键词 nanomicelle Doxorubicin Thin-film hydration method Single factor
下载PDF
Treatment of colorectal cancer by anticancer and antibacterial effects of hemiprotonic phenanthroline-phenanthroline^(+) with nanomicelle delivery
2
作者 Yingying Zhang Zizhen Zhao +5 位作者 Jingli Li Qinghua Wang Zhigang Fan Zhibo Yuan Yixiao Feng Ailing Fu 《Asian Journal of Pharmaceutical Sciences》 SCIE CAS 2023年第3期79-91,共13页
Colorectal cancer(CRC)is a common digestive tract tumor worldwide.Specific microorganisms,including Fusobacterium nucleatum(F.nucleatum)and Escherichia coli(E.coli),are abundant in colonic mucosa and can promote the c... Colorectal cancer(CRC)is a common digestive tract tumor worldwide.Specific microorganisms,including Fusobacterium nucleatum(F.nucleatum)and Escherichia coli(E.coli),are abundant in colonic mucosa and can promote the cancer progression and malignancy.Therefore,a therapeutic strategy is proposed to deliver effective drugs to colorectum for both anticancer and antibacteria.Here we used thin-film dispersionmethod to encapsulate hemiprotonic phenanthroline-phenanthroline^(+)(ph-ph^(+))into nanomicelle.The results showed that the drug-loading nanomicelle had good dispersion,and the particle size was about 28 nm.In vitro assay indicated that the nanomicelle was active against CRC-related obligate and facultative anaerobes.In human CRC cells,the nanomicelle could effectively inhibit cell proliferation and induce apoptosis.In vivo distribution showed that the nanomicelle could release ph-ph^(+) mainly in the colorectum.In CRC model mice,the nanomicelle significantly reduced tumor number and volume,and decreased the bacteria load and colorectal inflammation.Together,the study identifies that the ph-ph^(+) nanomicelle has the potential to apply in treating CRC,and also suggests that anticancer combined with antimicrobial therapy would be a feasible way for CRC therapy. 展开更多
关键词 CRC Drug-loading nanomicelle ANTIBACTERIA INFLAMMATION
下载PDF
Preparation Process of Plumbagin Nanomicelle In-situ Gel
3
作者 Xuemei LU Wanyu ZUO +4 位作者 Yun LI Weiyu WANG Ruyin DONG Luyang LU Jizhong ZHANG 《Medicinal Plant》 2023年第6期35-38,42,共5页
[Objectives]To prepare plumbagin nanomicelle(PLB-N)in-situ gel,and optimize the formulation and process.[Methods]PLB-N was prepared by self-assembly method,and the optimal formulation of PLB-N in-situ gel was determin... [Objectives]To prepare plumbagin nanomicelle(PLB-N)in-situ gel,and optimize the formulation and process.[Methods]PLB-N was prepared by self-assembly method,and the optimal formulation of PLB-N in-situ gel was determined by orthogonal experiment design and single factor method.[Results]The optimal preparation process for PLB-N was a drug to lipid ratio of 1:3,a Tween 80 content of 5%,an ethanol content of 7.5%of the hydration medium,a magnetic stirring speed of 2200 rpm,a stirring time of 30 min,and an ultrasound time of 10 min.The optimal formulation of PLB-N in-situ gel was 22%of poloxamer 407,6%of poloxamer 188,and 1:1 of PLB-N to water.The encapsulation efficiency of PLB-N prepared with the optimal formula was(95.8%±0.4%),and the average particle size was(75.19±1.14)nm,and the Zeta potential was(-20.73±1.19)mv.[Conclusions]PLB-N in-situ gel had stable and reliable preparation process,uniform content,and broad application prospects. 展开更多
关键词 PLUMBAGIN nanomicelle In-situ gel Preparation process
下载PDF
青蒿琥酯纳米胶束制备及其体内药动学、抗肿瘤活性研究
4
作者 陈永顺 杨斌 《中成药》 CAS CSCD 北大核心 2024年第5期1457-1465,共9页
目的制备青蒿琥酯纳米胶束,并考察体内药动学和抗肿瘤活性。方法以聚乙二醇单甲醚-聚乳酸-聚组氨酸(mPEG-PLA-PHis)为载体制备纳米胶束,单因素试验结合Box-Behnken响应面法优化处方,测定包封率、载药量、沉降率、粒径、Zeta电位、体外... 目的制备青蒿琥酯纳米胶束,并考察体内药动学和抗肿瘤活性。方法以聚乙二醇单甲醚-聚乳酸-聚组氨酸(mPEG-PLA-PHis)为载体制备纳米胶束,单因素试验结合Box-Behnken响应面法优化处方,测定包封率、载药量、沉降率、粒径、Zeta电位、体外释药。12只H_(22)荷瘤小鼠随机分为2组,分别尾静脉注射给予青蒿琥酯注射液和青蒿琥酯纳米胶束(1 mg/kg),于不同时间点采血,HPLC法测定青蒿琥酯血药浓度,计算主要药动学参数。36只H_(22)肝癌荷瘤小鼠随机分为6组,即模型组(生理盐水)、阳性组(20 mg/kg环磷酰胺)、青蒿琥酯注射液组(30 mg/kg)及青蒿琥酯纳米胶束低、中、高剂量组(10、20、30 mg/kg),末次给药3 d后记录体质量和瘤重,计算抑瘤率。结果最佳处方为mPEG-PLA-PHis与青蒿琥酯比例10.18∶1,青蒿琥酯质量浓度0.48 mg/mL,水化时间0.96 h,包封率、载药量、沉降率、粒径、Zeta电位分别为(94.27±1.26)%、(8.26±0.18)%、(4.19±0.20)%、(65.14±4.96)nm、-(17.64±1.06)mV。纳米胶束在弱酸性介质中的累积释放度高于在弱碱性介质中,具有pH敏感性。与注射液比较,纳米胶束t_(1/2)、MRT延长(P<0.01),CL降低(P<0.01),AUC_(0~t)升高(P<0.01);与模型组比较,青蒿琥酯纳米胶束不同剂量组小鼠体质量无明显变化(P>0.05),瘤重下降(P<0.05,P<0.01),以中剂量组更明显,抑瘤率达55.40%。结论青蒿琥酯纳米胶束包封率较高,体内抗肿瘤活性较强。 展开更多
关键词 青蒿琥酯 纳米胶束 制备 体内药动学 抗肿瘤活性 聚乙二醇单甲醚-聚乳酸-聚组氨酸(mPEG-PLA-PHis) HPLC H_(22)肝癌细胞
下载PDF
甘草-淫羊藿活性成分配伍抗肝癌复方纳米胶束制备与评价
5
作者 郝腾 赵烽栋 +5 位作者 孙正 李艳丽 徐可昕 赵烽 陈大全 许卉 《烟台大学学报(自然科学与工程版)》 CAS 2024年第4期439-445,共7页
基于晚期肝细胞癌(HCC)高侵袭性和对常规化疗的固有耐药性,设计开发了共递送中药活性成分淫羊藿次苷Ⅱ(ICAⅡ)和甘草次酸(GA)的抗肝癌复方纳米胶束。通过单因素及正交实验设计进行处方和工艺优化,在mPEG-PCL-Phe(Boc)为载体材料、ICAⅡ... 基于晚期肝细胞癌(HCC)高侵袭性和对常规化疗的固有耐药性,设计开发了共递送中药活性成分淫羊藿次苷Ⅱ(ICAⅡ)和甘草次酸(GA)的抗肝癌复方纳米胶束。通过单因素及正交实验设计进行处方和工艺优化,在mPEG-PCL-Phe(Boc)为载体材料、ICAⅡ与GA质量比4∶1、药辅质量比1∶9、水浴温度45℃、水化体积4 mL的最佳工艺条件下制备出复方胶束。该复方聚合物胶束具有典型的核-壳结构,粒径为(22.30±0.19)nm,PDI为0.29±0.01,Zeta电位为(-0.94±0.67)mV,胶体稳定性和生物相容性良好。在模拟正常生理条件(pH 7.4)下,可进行长达10 d的缓慢释放,符合一级动力学。与单药胶束相比,复方胶束能显著提高对人肝癌细胞的体外增殖抑制活性。显示甘草-淫羊藿活性成分复方配伍递送系统的抗肝癌潜力。 展开更多
关键词 肝癌 中药活性成分 淫羊藿次苷Ⅱ 甘草次酸 复方纳米胶束
下载PDF
α-倒捻子素/甘草酸纳米胶束的制备、表征及评价
6
作者 郑慧敏 王兰 +6 位作者 王艳 郭若曦 武改红 王军 张蕾 张秀君 李雪 《现代食品科技》 CAS 北大核心 2024年第8期61-69,共9页
制备α-倒捻子素/甘草酸纳米胶束(α-Mangostin/glycyrrhizic Acid Nanomicelles,α-MG/GA NMs),以提高α-倒捻子素(α-Mangostin,α-MG)的溶解度和抗氧化活性。以甘草酸(Glycyrrhizic Acid,GA)为载体制备α-MG/GA NMs,并进行工艺优化,... 制备α-倒捻子素/甘草酸纳米胶束(α-Mangostin/glycyrrhizic Acid Nanomicelles,α-MG/GA NMs),以提高α-倒捻子素(α-Mangostin,α-MG)的溶解度和抗氧化活性。以甘草酸(Glycyrrhizic Acid,GA)为载体制备α-MG/GA NMs,并进行工艺优化,表征和体外释放度、体外抗氧化活性评价。结果表明,在最佳工艺下制得的α-MG/GA NMs中α-MG溶解度为232.65μg/mL,比水中溶解度大了近1163倍;α-MG/GA NMs粒径为123.46 nm、PDI为0.24、Zeta电位为-20.94 mV;透射电镜(TEM)和扫描电镜(SEM)显示其为类球形;冻干后在光照、高温、高湿条件下稳定性良好;傅里叶红外光谱(FT-IR)显示α-MG与GA可能发生氢键相互作用;体外释放结果表明α-MG/GA NMs能促进α-MG释放,具有缓释效果,在pH值7.4、5.0的释放介质中24 h累积释放率分别为47.03%、40.56%;与游离α-MG相比,α-MG/GA NMs的抗氧化活性更强,且GA与α-MG具有协同抗氧化作用,对DPPH自由基、ABTS+自由基清除作用的协同指数(CI值)分别为0.62、0.58。该研究制备的α-MG/GA NMs提高了α-MG的溶解度与抗氧化活性,为α-MG在食品、药品、化妆品等领域的应用提供了理论基础。 展开更多
关键词 α-倒捻子素 甘草酸 纳米胶束 溶解度 抗氧化
下载PDF
姜黄素纳米胶束的制备、表征及抗酒精性肝病体外活性评价
7
作者 李禄辉 耿广平 +2 位作者 徐磊 张志坤 蒲晓辉 《中国药房》 CAS 北大核心 2024年第10期1203-1208,共6页
目的制备并表征姜黄素纳米胶束(简称“Cur/mPEG-PBLA胶束”),并评价其抗酒精性肝病的体外活性。方法以聚乙二醇-聚天冬氨酸苄酯嵌段共聚物(mPEG-PBLA)为载体,采用透析法制备Cur/mPEG-PBLA胶束;观察其外观和显微形态,检测其粒径、多分散... 目的制备并表征姜黄素纳米胶束(简称“Cur/mPEG-PBLA胶束”),并评价其抗酒精性肝病的体外活性。方法以聚乙二醇-聚天冬氨酸苄酯嵌段共聚物(mPEG-PBLA)为载体,采用透析法制备Cur/mPEG-PBLA胶束;观察其外观和显微形态,检测其粒径、多分散性指数、Zeta电位、包封率及载药量,并进行体外释放、pH稳定性、热稳定性、稀释稳定性、储存稳定性、血浆稳定性考察和溶血实验。以人肝癌细胞、正常肝细胞为对象,以Cur对照品溶液为参照,采用无水乙醇干预建立酒精性肝病细胞模型,评价Cur/mPEG-PBLA胶束对酒精性肝病的体外预防和改善作用。结果所制Cur/mPEG-PBLA胶束显淡黄色乳光,呈圆球形且分布均匀,平均粒径约140 nm,多分散性指数<0.3,Zeta电位为(-8.15±0.05)mV;包封率及载药量分别为(73.26±3.16)%、(4.87±0.42)%。Cur对照品在10 h时的累积释放率接近80%;Cur/mPEG-PBLA胶束在8 h时的累积释放率仅为28.94%,在48 h时的累积释放率才达48.25%。Cur/mPEG-PBLA胶束的pH稳定性、热稳定性均优于Cur对照品溶液,稀释稳定性、储存稳定性、血浆稳定性均较好,且不会引发溶血现象。Cur对照品溶液和Cur/mPEG-PBLA胶束对2种细胞的酒精性损伤均有不同程度的体外预防和改善作用;且作用48 h时,Cur/mPEG-PBLA胶束的上述作用均显著优于同质量浓度的Cur对照品溶液(P<0.05)。结论Cur/mPEGPBLA胶束可提高Cur的pH稳定性、热稳定性,延缓其释放速度,同时具有更强的体外抗酒精性肝病活性。 展开更多
关键词 姜黄素 纳米胶束 酒精性肝病 预防 改善 体外活性
下载PDF
伏立康唑TPGS-Cremophor EL眼用纳米胶束的制备及体外抗白色念珠菌评价
8
作者 曾甜 王欣宜 +4 位作者 彭澳 刘雪 文宝程 王凯月 田宝成 《滨州医学院学报》 2024年第1期26-31,共6页
目的构建基于α-生育酚聚乙二醇琥珀酸酯-聚氧乙烯蓖麻油EL的眼用混合胶束,并负载抗菌药物伏立康唑(TPGS-EL/VRC),探讨该纳米胶束的眼部药物递送性能及体外抗白色念珠菌效果。方法薄膜水化法制备TPGS-EL/VRC混合胶束,纳米激光粒度仪测... 目的构建基于α-生育酚聚乙二醇琥珀酸酯-聚氧乙烯蓖麻油EL的眼用混合胶束,并负载抗菌药物伏立康唑(TPGS-EL/VRC),探讨该纳米胶束的眼部药物递送性能及体外抗白色念珠菌效果。方法薄膜水化法制备TPGS-EL/VRC混合胶束,纳米激光粒度仪测定其粒径分布与Zeta电位,透射电子显微镜考察其形貌,高效液相色谱法测定载药量及包封率。通过细胞毒性试验和鸡胚绒毛尿囊膜(HET-CAM)试验评价TPGS-EL/VRC的体外生物相容性。利用流式细胞仪研究角膜上皮细胞(HCE-T)对纳米胶束的摄取能力及细胞摄取途径。通过体外抗真菌活性试验和抑菌环试验评估纳米胶束对白色念珠菌C.albican的抗菌能力。结果TPGS-EL/VRC混合胶束粒径为(109.63±0.25)nm,电位为(-29.3±0.20)mV,呈球形粒子,对VRC具有较好的包封率。纳米胶束对HCE-T细胞毒性低,生物相容性好。TPGS-EL混合胶束有效提高了HCE-T细胞对药物的摄取,为溶液组的5.8倍。在两种体外培养模型中均表现出更好的抗白色念珠菌能力。结论TPGS-EL/VRC纳米胶束具有良好的制剂学性质及生物相容性,展示了优异的促进VRC细胞内转运性能及体外抗白色念珠菌药效,为临床眼部真菌疾病的高效治疗提供了一种创新递送载体。 展开更多
关键词 伏立康唑 α-生育酚聚乙二醇琥珀酸酯 纳米胶束
下载PDF
聚氨酯基可控释放微纳米材料结构设计及应用研究进展
9
作者 师文钊 张领 +3 位作者 刘瑾姝 陆少锋 吴若楠 崔君洁 《纺织高校基础科学学报》 CAS 2024年第3期30-45,共16页
聚氨酯因其结构的多孔性、灵敏的刺激响应性以及与其他无机或有机材料复合的可加工性能,被广泛用于微胶囊、纳米胶束、纳米水凝胶等可控释放材料的制备研究。分析了聚氨酯用于微胶囊、纳米胶束、纳米水凝胶等可控释放材料研究的结构设... 聚氨酯因其结构的多孔性、灵敏的刺激响应性以及与其他无机或有机材料复合的可加工性能,被广泛用于微胶囊、纳米胶束、纳米水凝胶等可控释放材料的制备研究。分析了聚氨酯用于微胶囊、纳米胶束、纳米水凝胶等可控释放材料研究的结构设计思路,并详述了不同制备方法对聚氨酯基可控释放材料可控释放性能的影响。主要介绍了界面聚合法和乳液聚合法制备单壳层/双壳层微胶囊、化学交联法制备刺激响应型纳米胶束以及物理交联、化学交联和互穿网络技术制备刺激响应型纳米水凝胶。同时总结了聚氨酯基可控释放微纳米材料在纺织化工、医用、农业等领域的应用。分析了聚氨酯基可控释放材料研究中存在的关键问题,并对其未来应用发展方向进行了展望。 展开更多
关键词 聚氨酯 微胶囊 可控释放 纳米胶束 纳米水凝胶
下载PDF
基于甜茶苷的漆黄素载药纳米胶束的制备及其抗结肠炎活性
10
作者 肖海蓉 吴祥根 《青岛科技大学学报(自然科学版)》 CAS 2024年第5期49-56,共8页
制备基于两亲性甜茶苷的漆黄素载药纳米胶束(Fis/Rub胶束),以提高漆黄素的药代动力学特性和疾病治疗效果。采用薄膜分散法制备Fis/Rub胶束,并对其理化性质进行测定;采用亚铁还原能力实验检测Fis/Rub胶束的抗氧化活性;透析法和高效液相... 制备基于两亲性甜茶苷的漆黄素载药纳米胶束(Fis/Rub胶束),以提高漆黄素的药代动力学特性和疾病治疗效果。采用薄膜分散法制备Fis/Rub胶束,并对其理化性质进行测定;采用亚铁还原能力实验检测Fis/Rub胶束的抗氧化活性;透析法和高效液相色谱法检测Fis/Rub胶束的体外释放能力;考察Fis/Rub胶束的药代动力学特性和体内抗结肠炎活性。所得Fis/Rub胶束的粒径为(7.6±1.2)nm,电位为(-3.86±0.43)mV。甜茶苷纳米胶束可有效包封漆黄素;提高漆黄素在水中的溶解度((19.12±0.84)mg·mL^(-1));改善漆黄素的体外释放;增强漆黄素的抗氧化活性。大鼠体内药物动力学结果显示,与漆黄素混悬液相比,Fis/Rub胶束可提高漆黄素的口服生物利用度达5.5倍。药效学研究表明,口服Fis/Rub胶束可有效改善硫酸葡聚糖盐(DSS)诱导的小鼠溃疡性结肠炎的治疗效果。Fis/Rub这一新型制剂改善了漆黄素水溶性差等不足,具有潜在的进一步开发研究和临床意义。 展开更多
关键词 漆黄素 甜茶苷 纳米胶束 药物载体 溃疡性结肠炎
下载PDF
Preparation and Characterization of Florfenicol/Chitosan-stearic Acid Polymer Nanomicelle and Its Antibiotic Properties
11
作者 齐晓丹 JIA Xile 宋益民 《Journal of Wuhan University of Technology(Materials Science)》 SCIE EI CAS 2018年第4期1007-1013,共7页
Amphiphilic CS-SA polymers were prepared using the SA modified by small molecule water-soluble chitosan, and CS-SA nanomicelles and FF/CS-SA nanomicelles were prepared by using CSSA polymers as the material with dialy... Amphiphilic CS-SA polymers were prepared using the SA modified by small molecule water-soluble chitosan, and CS-SA nanomicelles and FF/CS-SA nanomicelles were prepared by using CSSA polymers as the material with dialysis-ultrasound method. CS-SA polymers, CS-SA nanomicelles, and FF/CS-SA nanomicelles were characterized by FT-IR, TGA, and SEM. Results showed that the SA was grafted to the amino of CS by amide bond. CS-SA nanomicelles and FF/CS-SA nanomicelles were spherical, smooth without fold. The influence of different molar ratio of FF to CS-SA polymers on the encapsulation efficiency and drug-loading rate determined the best molar ratio that was 1:1.09. In vitro release experiments, drug release performance study found that hydrophobic drug releasing from FF/CS-SA nanomicelles presented sustainedrelease. In vitro bacteriostasis experiments, when the concentration was higher than 4.98 mg/mL, FF/CSSA nanomicelles had antibacterial action and a positive correlation with concentration. The results revealed that amphiphilic chitosan derivative nanomicelles were carriers with broad prospects, increasing solubility of hydrophobic drugs and presenting sustained release for hydrophobic drugs, which provided a new research idea for drug delivery and targeted drug delivery of hydrohobic drugs. 展开更多
关键词 nanomicelle water-soluble chitosan hydrophobic drug antibacterial activity
下载PDF
甘草苷纳米胶束的制备与评价 被引量:1
12
作者 邢小燕 果秋婷 +1 位作者 徐长青 惠毅 《西北药学杂志》 CAS 2023年第2期129-134,共6页
目的 制备甘草苷纳米胶束(Lip-NMs)以提高药物的渗透性,并通过衰老模型大鼠评估其抗衰老作用。方法 以聚氧乙烯聚氧丙烯醚嵌段共聚物(Pluronic?F127)和聚乙烯己内酰胺-聚醋酸乙烯酯-聚乙二醇接枝共聚物(Soluplus?)作为载体材料,采用溶... 目的 制备甘草苷纳米胶束(Lip-NMs)以提高药物的渗透性,并通过衰老模型大鼠评估其抗衰老作用。方法 以聚氧乙烯聚氧丙烯醚嵌段共聚物(Pluronic?F127)和聚乙烯己内酰胺-聚醋酸乙烯酯-聚乙二醇接枝共聚物(Soluplus?)作为载体材料,采用溶剂蒸发-薄膜水化分散法将甘草苷制备成纳米胶束,并以临界胶束浓度、稀释稳定性、粒径分布、多聚分散系数(PDI)、Zeta电位和包封率作为评价指标,通过单因素实验确定Lip-NMs处方中Pluronic?F127和Soluplus?用量的配比;考察甘草苷混悬液和Lip-NMs在不同pH介质溶液中的药物释放情况;评估Lip-NMs对Caco-2细胞的毒性,并进行细胞跨膜转运研究;比较甘草苷混悬液和Lip-NMs对D-半乳糖所致衰老模型大鼠的抗衰老作用。结果 通过综合评估确定Lip-NMs的最优处方:Pluronic?F127和Soluplus?的质量比为25∶75;在透射电镜下可观察到Lip-NMs呈圆整球形;Lip-NMs在不同pH介质溶液中均表现为缓慢释药特性;Lip-NMs能够有效提高药物的渗透性;与对照组相比,Lip-NMs可显著提高衰老模型大鼠脑组织中超氧化物歧化酶(superoxide dismutase, SOD)、谷胱甘肽过氧化酶(glutathione peroxidase, GSH-Px)的含量,降低丙二醛(malondialdehyde, MDA)的含量,有效提高脑的抗氧化能力。结论 将Pluronic?F127和Soluplus?作为载体材料,将甘草苷制备成纳米胶束,有望促进药物吸收,达到更好的抗衰老作用。 展开更多
关键词 甘草苷 纳米胶束 渗透性 吸收 抗衰老
下载PDF
厚朴酚药理作用及增溶研究进展 被引量:3
13
作者 曹佳 兰星 +2 位作者 邱晨旭 夏明 赵兴华 《动物医学进展》 北大核心 2023年第2期103-106,共4页
厚朴酚是从中药厚朴的根和茎皮中分离出来的联苯酚类化合物,具有抑菌、抗炎、抗氧化、抗寄生虫等生物学作用。厚朴酚在提高家禽生长性能、抗氧化、免疫功能及肠道健康方面有良好的应用效果。但由于厚朴酚在水中的溶解度低、生物利用度... 厚朴酚是从中药厚朴的根和茎皮中分离出来的联苯酚类化合物,具有抑菌、抗炎、抗氧化、抗寄生虫等生物学作用。厚朴酚在提高家禽生长性能、抗氧化、免疫功能及肠道健康方面有良好的应用效果。但由于厚朴酚在水中的溶解度低、生物利用度不高限制了其在临床上的应用。为了提高厚朴酚的溶解度,扩大其临床应用,国内外学者对厚朴酚进行了大量研究,包括应用固体分散体、纳米药物、包合物等技术。论文就厚朴酚的药理作用及其增溶研究进行综述,旨在为厚朴酚和其他难溶性中药活性成分的增溶研究提供参考。 展开更多
关键词 厚朴酚 固体分散体 纳米粒 纳米胶束 包合物
下载PDF
载丹参酮ⅡA ROS敏感纳米胶束的制备及体外抗炎作用 被引量:2
14
作者 刘美萱 刘沙 +1 位作者 张蓬 孙考祥 《烟台大学学报(自然科学与工程版)》 CAS 2023年第2期171-177,共7页
本研究针对炎症微环境构建了一种ROS敏感纳米给药系统以解决丹参酮ⅡA的递送难题。首先合成了聚乙二醇-聚硫化丙烯(mPEG-PPS)两亲性载体材料,通过^(1)H-NMR进行结构确认,芘荧光探针法测定临界胶束浓度为0.030 1 mg/mL。采用薄膜分散法... 本研究针对炎症微环境构建了一种ROS敏感纳米给药系统以解决丹参酮ⅡA的递送难题。首先合成了聚乙二醇-聚硫化丙烯(mPEG-PPS)两亲性载体材料,通过^(1)H-NMR进行结构确认,芘荧光探针法测定临界胶束浓度为0.030 1 mg/mL。采用薄膜分散法制备载丹参酮ⅡA的纳米胶束,根据透射电镜可知该纳米胶束为球状结构,分布均匀,粒径为151.4 nm, PDI为0.196,zeta电位为-8.29 mV,体系相对稳定。在ROS条件下纳米胶束有效释放丹参酮ⅡA,释放速率与H_(2)O_(2)浓度有关。该纳米胶束浓度达到最大时,溶血率仍小于5%,说明其具有良好的生物相容性。MTT结果显示该纳米胶束对LPS诱导的炎症巨噬细胞RAW 264.7增殖具有良好的抑制效果;ELISA试剂盒检测RAW 264.7细胞中肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)的含量均明显减低。综上结果表明,该纳米胶束具有响应炎症氧化微环境优势,在体外抗炎作用方面发挥出巨大潜力。 展开更多
关键词 丹参酮ⅡA ROS敏感纳米胶束 抗炎作用 薄膜分散法
下载PDF
高良姜素纳米胶束制备及其体内药动学研究 被引量:4
15
作者 栗忠强 决利利 +1 位作者 万亚存 吕东霞 《中成药》 CAS CSCD 北大核心 2023年第5期1410-1416,共7页
目的制备高良姜素纳米胶束,并考察其体内药动学。方法薄膜水化法制备纳米胶束,测定其粒径、Zeta电位、稳定性、体外释药。以水化体积、水化温度、聚乙二醇聚己内酯用量为影响因素,包封率、载药量、沉降率为评价指标,单因素试验优化处方... 目的制备高良姜素纳米胶束,并考察其体内药动学。方法薄膜水化法制备纳米胶束,测定其粒径、Zeta电位、稳定性、体外释药。以水化体积、水化温度、聚乙二醇聚己内酯用量为影响因素,包封率、载药量、沉降率为评价指标,单因素试验优化处方工艺。18只大鼠随机分为3组,分别灌胃给予高良姜素、高良姜素自微乳、高良姜素纳米胶束的0.5%CMC-Na混悬液(40 mg/kg),于不同时间点采血,HPLC法测定高良姜素血药浓度,计算主要药动学参数。结果最佳处方为水化体积20 mL,水化温度45℃,聚乙二醇聚己内酯用量220 mg,包封率为(95.42±1.14)%,载药量为(7.92±0.15)%,沉降率为(0.85±0.18)%,粒径为(78.76±5.94)nm,Zeta电位为-(33.40±1.28)mV。纳米胶束冻干粉在60 d内粒径、包封率无明显变化,模拟胃液、模拟肠液中其48 h内累积释放度高于原料药。与原料药、自微乳比较,纳米胶束t_(max)、t_(1/2)延长(P<0.05,P<0.01),C_(max)、AUC_(0~t)、AUC_(0-∞)升高(P<0.05,P<0.01),相对生物利用度增加至3.64倍。结论纳米胶束可有效促进高良姜素口服吸收,改善其生物利用度。 展开更多
关键词 高良姜素 纳米胶束 制备 体内药动学 薄膜水化法 单因素试验 HPLC
下载PDF
Melphalan-loaded methoxy poly(ethylene glycol)-poly(D,L-lactide)copolymer nanomicelles in the treatment of multiple myeloma
16
作者 Yingying Chen Qiang Zeng +9 位作者 Bingyang Chu Zhigang Liu Xue Wei Mengran Chen Peipei Yang Minghai Tang Ting Niu Yongqian Jia Ying Qu Zhiyong Qian 《Chinese Chemical Letters》 SCIE CAS CSCD 2023年第9期193-198,共6页
Multiple myeloma(MM)is the second most common hematological tumor characterized by the proliferation of monoclonal plasma cells.Melphalan(MEL)is commonly used in the treatment of MM and is especially essential for pat... Multiple myeloma(MM)is the second most common hematological tumor characterized by the proliferation of monoclonal plasma cells.Melphalan(MEL)is commonly used in the treatment of MM and is especially essential for patients undergoing autologous stem cell transplantation(ASCT).Although many drugs for MM have been developed in recent years,chemotherapy followed by ASCT remains the optimal option.Melphalan,the backbone of the conditioning regimen,brings severe toxicities at a high dose.Nanodrug delivery systems enable drugs to be highly effective and have low toxicity.In this study,methoxy poly(ethylene glycol)-poly(D,L-lactide)copolymer(MPEG-PDLLA)was chosen to encapsulate melphalan,and the characteristics,effectiveness,and safety of MEL/MPEG-PDLLA in vitro and in vivo were investigated.MEL/MPEG-PDLLA showed slow release and was easily engulfed by MM cells despite a result of the antitumor assay comparable to that of free melphalan in vitro.The in vivo results showed that MEL/MPEG-PDLLA could significantly alleviate tumor burden and prolong survival time without increasing the toxicity to vital organs.In addition,MEL/MPEG-PDLLA could significantly reduce the damage to the intestinal mucosa caused by melphalan.In conclusion,MEL/MPEG-PDLLA shows improved antitumor activity and has the potential to alleviate pains of MM patients undergoing ASCT. 展开更多
关键词 MELPHALAN Multiple myeloma MPEG-PDLLA nanomicelle
原文传递
Construction of AIEgen functionalized nanomicelles and their stability study through‘seesaw-like'fluorescence changes
17
作者 Xiaotong Wang Shizhu Chen +5 位作者 Yaru Jia Kaihan Zhang Lili Ma Luwei Li Xingjie Liang Jinchao Zhang 《Chinese Chemical Letters》 SCIE CAS CSCD 2023年第6期382-386,共5页
As nanocarriers,nanomicelles play vital roles in the toolbox of drug delivery.The stability of nanomicelles affects the nanomedicines'bioactivity.Therefore,it is important to understand the stability of nanomicell... As nanocarriers,nanomicelles play vital roles in the toolbox of drug delivery.The stability of nanomicelles affects the nanomedicines'bioactivity.Therefore,it is important to understand the stability of nanomicelles for further improvements.Here,we report a strategy to construct new nanomicelles(NM)by introducing aggregation-induced emission(AIE)functional group tetraphenylethylene(TPE)in the component polymer vitamin E(D-α-tocopheryl polyethylene glycol 1000 succinate)(TPGS).The stability of doxorubicin(DOX)loaded nanomicelles DOX@NM in different conditions was studied by fluorescence analysis.The fluorescence changes of DOX@NM are‘seesaw-like'when they transform between assembled and disassembled forms.In the assembled form,TPE gives emission from AIE effect,while in the disassembled form,the fluorescence of DOX is observed due to the disappearance of ACQ effect. 展开更多
关键词 Polymer nanomicelles Aggregation-induced emission Fluorescence ratio STABILITY Drug delivery system
原文传递
Peptide-assembled siRNA nanomicelles confine MnOx-loaded silicages for synergistic chemical and gene-regulated cancer therapy
18
作者 Jingjing Li Juanjuan Wei +4 位作者 Yixuan Gao Qi Zhao Jianghui Sun Jin Ouyang Na Na 《Chinese Chemical Letters》 SCIE CAS CSCD 2023年第4期453-458,共6页
Chemodynamic therapy(CDT) is a promising therapeutic approach for in situ cancer treatment, but it is still hindered by inefficient single-modality treatment and the weak targeted delivery of reagents into mitochondri... Chemodynamic therapy(CDT) is a promising therapeutic approach for in situ cancer treatment, but it is still hindered by inefficient single-modality treatment and the weak targeted delivery of reagents into mitochondria(the main site of intracellular ROS production). Herein, to obtain a multimodal strategy,peptide-assembled si RNA nanomicelles were prepared to confine ultrasmall MnOxin small silica cages(silicages), which is convenient for synergistic chemical and gene-regulated cancer therapy. Given the free energy and versatility of small silicages, as well as the excellent Fenton-like activity of ultrasmall MnOx,MnOx-inside-loaded silicages(10 nm) were prepared for CDT delivery to mitochondria. Subsequently, to obtain a synergistic CDT and gene silencing treatment, the peptide-mediated assembly of si RNA and MnOx-loaded silicages were employed to obtain silicage@MnOx-si RNA nanomicelles(SMS NMs). After multiple modifications, sequential cancer cell-targeted delivery, GSH-controlled reagent release of si RNA and mitochondria-targeted delivery of MnOx-loaded silicages were successfully achieved. Finally, by both in vitro and in vivo experiments, SMS NMs were confirmed to be effective for synergistic chemical and gene-regulated cancer therapy. Our findings expand the applications of silicages and initiate the development of multimodal CDT. 展开更多
关键词 Peptide-assembled siRNA nanomicelles MnOx-loaded silicages GSH-stimulated release Mitochondria-targeted delivery Cancer therap
原文传递
载木犀草素纳米胶束的制备及其大鼠体内药动学研究
19
作者 夏志丹 张忠元 《中国现代中药》 CAS 2023年第10期2179-2185,共7页
目的:制备木犀草素纳米胶束(LUT-NMs),以提高药物的口服生物利用度。方法:以聚氧乙烯聚氧丙烯醚嵌段共聚物Pluronic F127和Pluronic P123作为纳米胶束载体材料,使用溶剂蒸发-薄膜水化分散法将木犀草素制备成聚合物胶束;以LUT-NMs处方中... 目的:制备木犀草素纳米胶束(LUT-NMs),以提高药物的口服生物利用度。方法:以聚氧乙烯聚氧丙烯醚嵌段共聚物Pluronic F127和Pluronic P123作为纳米胶束载体材料,使用溶剂蒸发-薄膜水化分散法将木犀草素制备成聚合物胶束;以LUT-NMs处方中的聚合物与药物质量比、Pluronic F127与Pluronic P123质量比作为考察因素,以包封率、粒径分布和多聚分散系数(PDI)作为评价指标,采用二因素三水平中心复合响应面法优化了LUT-NMs的处方;通过透射电镜、稀释稳定性和体外药物释放对LUT-NMs的理化性质进行了评价;考察了大鼠口服LUT-NMs的相对生物利用度。结果:实验设计获得LUT-NMs的最佳处方为聚合物与药物质量比为45∶1,Pluronic F127与Pluronic P123质量比为5∶1;在透射电镜下可观察到LUT-NMs呈圆整球形,LUT-NMs的稀释稳定性良好,在不同pH介质溶液中释药速率缓慢且释药速率之间无差异;大鼠体内药动学结果显示,LUT-NMs可显著提高药物的达峰浓度,增加药物口服生物利用度。结论:将木犀草素制备成纳米胶束,可显著提高药物的口服生物利用度。 展开更多
关键词 木犀草素 纳米胶束 生物利用度 溶剂蒸发-薄膜水化分散法
下载PDF
基于大数据分析的纳米胶束技术在眼底药物递送中应用的技术机会研究
20
作者 彭海洲 《计算机应用文摘》 2023年第24期93-95,共3页
将纳米胶束技术作为基础技术,具有潜在的实现滴眼给药治疗眼底疾病的可能性,为科研人员提供了一种关于药物眼底递送技术的新的底层基础知识,也为眼底药物递送技术提供了技术机会。
关键词 大数据分析 纳米胶束 眼底递送
下载PDF
上一页 1 2 6 下一页 到第
使用帮助 返回顶部